New Assessment System in Measuring Symptom Distress in Cancer Patients

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT00505245
Status
Recruiting
Apply to this trial

Conditions

  • Caregiver
  • Health Care Provider
  • Malignant Neoplasm
  • Physician

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Interview — OTHER
    Complete interview
  • Quality-of-Life Assessment — OTHER
    Complete quality of life assessment
  • Questionnaire Administration — OTHER
    Complete questionnaires

Study Details

This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.

Key Dates

Start date
Apr 13, 1999
Status verified
Jan 2026
Primary completion
Apr 30, 2031
Completion
Apr 30, 2031

Study Design

Enrollment
6,500 participants (estimated)

Arms

  • Arm: Observational (questionnaire, QOL assessment, interview)
    Participants complete questionnaires and quality of life assessments, and may also complete interviews over 45 minutes periodically.

Primary Outcome Measure

MD Anderson Symptom Inventory (MDASI) tool or other MD Anderson-developed patient reported outcome (PRO) instrument validity [ Time Frame: Up to 21 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
M D Anderson Cancer CenterHoustonTexas77030
Xin Shelley Wang
713-745-3504
Xin Shelley Wang (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
M D Anderson Cancer Center· Houston, TX

Related Studies